Australia Biotechnology & Medical Research

Antisense Therapeutics Ltd (ANP)

Track

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Antisense Therapeutics Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
James Garner Director
Transaction date
Purchase
Price
317.56
Quantity 92,001
Value A$4,028,862
Ben Gil Price Director
Transaction date
Purchase
Price
169.90
Quantity 44,551
Value A$4,327,042
James Garner Director
Transaction date
Planned purchase
Price
173.50
Quantity 95,363
Value A$160,329
Charmaine Gittleson Director
Transaction date
Planned purchase
Price
0.05
Quantity 600,000
Value A$30,000
James Garner Director
Transaction date
Purchase
Price
0.07
Quantity 300,000
Value A$22,200
Ben Gil Price Director
Transaction date
Purchase
Price
0.08
Quantity 701
Value A$59
Ben Gil Price Director
Transaction date
Purchase
Price
0.09
Quantity 105,208
Value A$9,048
Ben Gil Price Director
Transaction date
Purchase
Price
0.09
Quantity 493,896
Value A$41,981
Mark Diamond Director
Transaction date
Purchase
Price
2,455.04
Quantity 46
Value A$112,932
Charmaine Gittleson Director
Transaction date
Purchase
Price
0.23
Quantity 133,333
Value A$30,667
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-21 2023-11-17 B Purchase James Garner Director
92,001
317.56
A$4,028,862 		92,001 317.56 A$4,028,862
2023-10-02 2023-09-26 B Purchase Ben Gil Price Director
44,551
169.90
A$4,327,042 		44,551 169.90 A$4,327,042
2023-08-22 2023-08-22 PP Planned purchase James Garner Director
95,363
173.50
A$160,329 		95,363 173.50 A$160,329
2023-08-22 2023-08-22 PP Planned purchase Charmaine Gittleson Director
600,000
0.05
A$30,000 		600,000 0.05 A$30,000
2023-05-11 2023-05-08 B Purchase James Garner Director
300,000
0.07
A$22,200 		300,000 0.07 A$22,200
2022-10-07 2022-10-03 B Purchase Ben Gil Price Director
701
0.08
A$59 		701 0.08 A$59
2022-10-04 2022-09-30 B Purchase Ben Gil Price Director
105,208
0.09
A$9,048 		105,208 0.09 A$9,048
2022-09-29 2022-09-29 B Purchase Ben Gil Price Director
493,896
0.09
A$41,981 		493,896 0.09 A$41,981
2021-12-22 2021-12-22 B Purchase Mark Diamond Director
46
2,455.04
A$112,932 		46 2,455.04 A$112,932
2021-11-11 2021-11-08 B Purchase Charmaine Gittleson Director
133,333
0.23
A$30,667 		133,333 0.23 A$30,667
Explore more

More insider trading research around Antisense Therapeutics Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Asia-Pacific